Sernova Corp. (TSE:SVA – Get Free Report)’s stock price reached a new 52-week low on Monday . The stock traded as low as C$0.37 and last traded at C$0.37, with a volume of 144113 shares trading hands. The stock had previously closed at C$0.40.
Analyst Upgrades and Downgrades
Separately, Raymond James set a C$1.50 target price on shares of Sernova and gave the company a “market perform” rating in a research note on Thursday, April 4th.
Check Out Our Latest Research Report on Sernova
Sernova Trading Down 7.5 %
Sernova (TSE:SVA – Get Free Report) last issued its quarterly earnings results on Monday, March 18th. The company reported C($0.03) earnings per share for the quarter, meeting analysts’ consensus estimates of C($0.03). As a group, sell-side analysts expect that Sernova Corp. will post -0.08 earnings per share for the current fiscal year.
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Stories
- Five stocks we like better than Sernova
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Generac Powers Ahead on the Electrification Mega-Trend
- Consumer Staples Stocks, Explained
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.